(Q34409346)

English

Subcutaneous Interferon Beta-1a Has a Positive Effect on Cognitive Performance in Mildly Disabled Patients with Relapsing-Remitting Multiple Sclerosis: 2-Year Results from the COGIMUS Study

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Subcutaneous Interferon Beta-1a Has a Positive Effect on Cognitive Performance in Mildly Disabled Patients with Relapsing-Remitting Multiple Sclerosis: 2-Year Results from the COGIMUS Study (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

0 references

multiple sclerosis

0 references

relapsing-remitting multiple sclerosis

0 references

author name string

Francesco Patti

1

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Maria Pia Amato

2

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Stefano Bastianello

3

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Luisa Caniatti

4

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Elisabetta Di Monte

5

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Fausto Lijoi

6

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Benedetta Goretti

7

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Silvia Messina

8

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Orietta Picconi

9

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Maria Rosalia Tola

10

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Maria Trojano

11

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 March 2009

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Therapeutic advances in neurological disorders

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

67-77

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Cognitive impairment in multiple sclerosis: evidence-based analysis and recommendations.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3002625

6 July 2018

The neuropsychiatry of multiple sclerosis: a review of recent developments

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3002625

6 July 2018

Early cognitive impairment in patients with clinically isolated syndrome suggestive of multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3002625

6 July 2018

Treatment of cognitive impairment in multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3002625

6 July 2018

Differential cognitive impairment for diverse forms of multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3002625

6 July 2018

Assessment of cognitive dysfunction in multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3002625

6 July 2018

Multiple sclerosis-related cognitive changes: a review of cross-sectional and longitudinal studies.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3002625

6 July 2018

Cognitive impairment and decline in different MS subtypes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3002625

6 July 2018

Are there protective treatments for cognitive decline in MS?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3002625

6 July 2018

Interferons and cognition

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3002625

6 July 2018

Neurotrophic factors in relapsing remitting and secondary progressive multiple sclerosis patients during interferon beta therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3002625

6 July 2018

The long-term safety and tolerability of high-dose interferon beta-1a in relapsing-remitting multiple sclerosis: 4-year data from the PRISMS study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3002625

6 July 2018

Treatment of neuropsychiatric syndromes in multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3002625

6 July 2018

Cognitive patterns and progression in multiple sclerosis: construction and validation of percentile curves

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3002625

6 July 2018

Cognitive dysfunction in multiple sclerosis: a review of recent developments

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3002625

6 July 2018

Fatigue associated with multiple sclerosis: diagnosis, impact and management

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3002625

6 July 2018

Depression and Cognitive Impairment in Disability-Free Early Multiple Sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3002625

6 July 2018

Cognitive dysfunction in multiple sclerosis: natural history, pathophysiology and management

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3002625

6 July 2018

Cognitive dysfunction in early-onset multiple sclerosis: a reappraisal after 10 years

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3002625

6 July 2018

Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3002625

6 July 2018

MRI correlates of cognitive dysfunction in multiple sclerosis patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3002625

6 July 2018

Improved delayed visual reproduction test performance in multiple sclerosis patients receiving interferon beta-1b.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3002625

6 July 2018

A health-related quality of life measure for multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3002625

6 July 2018

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3002625

6 July 2018

Development of a Rating Scale for Primary Depressive Illness

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3002625

6 July 2018

Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3002625

6 July 2018

The Rao's Brief Repeatable Battery and Stroop Test: normative values with age, education and gender corrections in an Italian population.

1 reference

https://api.crossref.org/works/10.1177%2F1756285608101379

21 January 2018

Cognitive fatigue in multiple sclerosis: findings from a two-wave screening project.

1 reference

https://api.crossref.org/works/10.1177%2F1756285608101379

21 January 2018

Health-related quality of life and its relationship to cognitive and emotional functioning in multiple sclerosis patients.

1 reference

https://api.crossref.org/works/10.1177%2F1756285608101379

21 January 2018

Cognitive function in primary progressive and transitional progressive multiple sclerosis: a controlled study with MRI correlates.

1 reference

https://api.crossref.org/works/10.1177%2F1756285608101379

21 January 2018

Effects of donepezil on memory and cognition in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1177%2F1756285608101379

21 January 2018

Measuring the functional impact of fatigue: initial validation of the fatigue impact scale.

1 reference

https://api.crossref.org/works/10.1177%2F1756285608101379

21 January 2018

Cognitive dysfunction in patients with clinically isolated syndromes or newly diagnosed multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1177%2F1756285608101379

21 January 2018

The influence of immunomodulation on psycho-neuroimmunological functions in benign multiple sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1756285608101379

21 January 2018

Cognitive slowing in multiple sclerosis is strongly associated with brain volume reduction

1 reference

https://api.crossref.org/works/10.1177%2F1756285608101379

21 January 2018

PRISMS-4: Long-term efficacy of interferon-beta-1a in relapsing MS.

1 reference

https://api.crossref.org/works/10.1177%2F1756285608101379

21 January 2018

Cognitive dysfunction evaluation in multiple sclerosis patients treated with interferon beta-1b: an open-label prospective 1 year study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3002625

27 October 2018

Neuropsychological effects of interferon beta-1a in relapsing multiple sclerosis. Multiple Sclerosis Collaborative Research Group.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3002625

27 October 2018

Effect sizes for interpreting changes in health status.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3002625

27 October 2018

Cognitive impairment in multiple sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21180642

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Age-related disability in multiple sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21180642

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cognitive impairment in early-onset multiple sclerosis. Pattern, predictors, and impact on everyday life in a 4-year follow-up

1 reference

https://pubmed.ncbi.nlm.nih.gov/21180642

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The association between cognitive impairment and physical disability in multiple sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21180642

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The influence of cognitive impairment on driving performance in multiple sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21180642

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cognitive dysfunction in multiple sclerosis.: II. Impact on employment and social functioning

1 reference

https://pubmed.ncbi.nlm.nih.gov/21180642

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neuropsychological, neuroradiological and clinical findings in multiple sclerosis. A 3 year follow-up study

1 reference

https://pubmed.ncbi.nlm.nih.gov/21180642

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1177/1756285608101379

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34409346&oldid=1754187264"